Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2019

Planlagt Fastgjort Låst Flyttet Genmab
2.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • B Offline
    B Offline
    Bella1
    wrote on sidst redigeret af
    #963

    Han er en rigtig god købmand for SIT land. og du kommer ret sikkert til at døje med ham de næste 5 år, men lad dig ikke mærke med noget.... 🙂

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #964

      Ja, der vil blive noget at rydde op efter ham. Han samler jo ikke selv alt det LO.. op som han smider.

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #965

        Ny video

        Her får I en hurtig TA-rundtur i følgende 5 aktier:
        Teva
        Bavarian
        Fingerprint
        Genmab
        Novo

        Just a moment...

        favicon

        (www.proinvestor.com)

        1 Reply Last reply
        0
        • P Offline
          P Offline
          peter12
          wrote on sidst redigeret af
          #966

          Ny video om sc dara https://www.youtube.com/watch?v=i6J6PcRWOdY

          1 Reply Last reply
          0
          • J Offline
            J Offline
            Jazzz
            wrote on sidst redigeret af
            #967

            Peter.. hvad siger de til sidst, som hindring for at alle går over på SC “drug prices, how farmacies deal with it and .... (?)”

            1 Reply Last reply
            0
            • J Offline
              J Offline
              Jazzz
              wrote on sidst redigeret af
              #968

              (Har man allerede en ide om, hvordan SC skal prissættes?)

              1 Reply Last reply
              0
              • P Offline
                P Offline
                peter12
                wrote on sidst redigeret af
                #969

                Han nævner co-pay bla.

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  polle1
                  wrote on sidst redigeret af
                  #970

                  God morgen og god dag 🙂

                  1 Reply Last reply
                  0
                  • T Offline
                    T Offline
                    transalp
                    wrote on sidst redigeret af
                    #971

                    Go morgen:) peter12, lovende klip om SC dara..

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Sukkeralf
                      wrote on sidst redigeret af
                      #972

                      Just a moment...

                      favicon

                      (www.firstwordpharma.com)

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #973

                        However, Darzalez’s success in GRIFFIN is nevertheless important in two key respects. The first is that it evaluated the same regimen being tested in PERSEUS, thus increasing the odds of success in the larger study. What’s more, and perhaps more importantly from a near-term perspective, having data in hand supporting the benefit of Darzalex plus VRd could be enough to convince some oncologists to starting using the combination.

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #974

                          “Although results of the ongoing PERSEUS trial will be required to enable approval of the regimen in this setting, data publication and inclusion in treatment guidelines could enable off-label use in the US and should further consolidate Darzalex as an option that should be considered for all first-line patients,” noted Deutsche Bank analyst Richard Parkes.

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #975

                            PERSEUS findings are expected sometime in 2022. Parkes said that adding the ASCT-eligible indication to Darzalex’s label will make up a meaningful portion of his $7.5 billion in projected sales for the drug in 2025, though his assumption of only 20% penetration leaves some room for upside.

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #976

                              Trump dropper forbud mod rabatter til indkøbsforeninger. https://medwatch.dk/secure/samfund/article11497065.ece

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                Plimsoller
                                wrote on sidst redigeret af
                                #977

                                Men ser nu ud til at rette fokus mod medicinalvirksomhederne.

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Plimsoller
                                  wrote on sidst redigeret af
                                  #978

                                  Link Preview Image
                                  Trump dropper lovindgreb - det kan blive dyrt for danske Novo Nordisk

                                  Donald Trumps forsøg på at skaffe amerikanerne billigere medicin led et knæk, da USA´s regering har droppet at tvinge sygekasser og forsikringsselskaberne til at sende deres rabatter videre til forbrugerne.

                                  favicon

                                  Finans (finans.dk)

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #979

                                    Sukkeralf. Mon ikke snart vi ser flere analytikere blive opmærksomme på at Dara vil blive brugt i flere og flere comboer. ( næsten ikke til at komme uden om ) . ?

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Plimsoller
                                      wrote on sidst redigeret af
                                      #980

                                      Notering på børsen i USA. https://borsen.dk/nyheder/virksomheder/artikel/1/384415/genmabs_milliardnotering_i_usa_ventes_klar_midt_i_naeste_uge.html?split=B&utm_source=forside&utm_campaign=nyhed_01

                                      1 Reply Last reply
                                      0
                                      • B Offline
                                        B Offline
                                        bibob
                                        wrote on sidst redigeret af
                                        #981

                                        Plimsoller. - pharma lobbyen og våben lobbyen er nok de 2 største interesseorganisationer i USA. Men vi ved jo at Trump'en lytter mere til våbenlobbyen. 😉

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          Plimsoller
                                          wrote on sidst redigeret af
                                          #982

                                          Bibob - Præcis, og yderligere så nærmer valget sig. Det er lidt svært at forudsige hvad han vil (og ikke mindst hvor meget magt han har til at gennemføre det). Der er vel grænser for hvor meget man kan styre igennem et dekret).

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger